Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Price / Earnings (ltm)

Acadia Pharmaceutica Price / Earnings (ltm) Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Price / Earnings (ltm) from 2011 to 2012. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Acadia Pharmaceutica Price / Earnings (ltm) for the quarter ending March 03, 2012 was 6.56 a -7.05% decrease of -0.46 year over year
  • Acadia Pharmaceutica Price / Earnings (ltm) for the last 12 months ending March 03, 2012 was 6.56 a -7.05% decrease of -0.46 year over year
  • Acadia Pharmaceutica Annual Price / Earnings (ltm) for 2012 was 6.56 a -1.92% decrease of -0.13 from 2011
  • Acadia Pharmaceutica Annual Price / Earnings (ltm) for 2012 was 6.68 a -3.77% decrease of -0.25 from 2011
  • Acadia Pharmaceutica Annual Price / Earnings (ltm) for 2012 was 6.94 a -1.21% decrease of -0.08 from 2011
Other Valuation Metrics:
  • Acadia Pharmaceutica Market Cap for the quarter ending March 03, 2018 was $2,802m a -21.48% decrease of -602m year over year
  • Acadia Pharmaceutica Price / Book for the quarter ending March 03, 2018 was 8.34 a 10.81% increase of 0.90 year over year
  • Acadia Pharmaceutica Enterprise Value for the quarter ending March 03, 2018 was $2,461m a -19.25% decrease of -474m year over year
View Chart On Koyfin

Quarterly ACAD Price / Earnings (ltm) Data

03/20126.56
03/20126.68
03/20126.94
02/20127.02
02/20127.15
02/20127.40
02/20127.40
02/20127.27
02/20126.94
02/20127.23

Annual ACAD Price / Earnings (ltm) Data

20126.56
20126.68
20126.94
20127.02
20127.15
20127.40
20127.40
20127.27
20126.94
20127.23